| Full Name | John Price |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 305 S 5th St, Enid, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376560904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 16520 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Complete Home Health Of Western Oklahoma | Enid, OK | Home health agency |
| Choice Hospice | Oklahoma city, OK | Hospice |
| Fairview Regional Medical Center Authority | Fairview, OK | Hospital |
| St Mary's Regional Medical Center | Enid, OK | Hospital |
| Integris Bass Baptist Health Center | Enid, OK | Hospital |
| Fairview Fellowship Home For Senior Citizens, Inc | Fairview, OK | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Regional Medical Center Authority | 4183943186 | 2 |
News Archive
Ambry Genetics today introduced The Ambry X-Linked Mental Retardation SuperPANEL™, a suite of genetic tests expected to pinpoint the cause of intellectual disability and X-linked mental retardation (XLMR).
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Is cellphone use detrimental to mental health? A new study from the University of Illinois finds that addiction to, and not simply use of, mobile technology is linked to anxiety and depression in college-age students.
Neuroscientists at Case Western Reserve University School of Medicine have discovered a new cell type in the part of the brain that processes our sense of smell.
› Verified 8 days ago
| Entity Name | Fairview Regional Medical Center Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316981657 PECOS PAC ID: 4183943186 Enrollment ID: O20150501000163 |
News Archive
Ambry Genetics today introduced The Ambry X-Linked Mental Retardation SuperPANEL™, a suite of genetic tests expected to pinpoint the cause of intellectual disability and X-linked mental retardation (XLMR).
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Is cellphone use detrimental to mental health? A new study from the University of Illinois finds that addiction to, and not simply use of, mobile technology is linked to anxiety and depression in college-age students.
Neuroscientists at Case Western Reserve University School of Medicine have discovered a new cell type in the part of the brain that processes our sense of smell.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Price, MD 3404 N Lincoln St, Enid, OK 73703-1607 Ph: (580) 242-1405 | John Price, MD 305 S 5th St, Enid, OK 73701-5832 Ph: (580) 233-6100 |
News Archive
Ambry Genetics today introduced The Ambry X-Linked Mental Retardation SuperPANEL™, a suite of genetic tests expected to pinpoint the cause of intellectual disability and X-linked mental retardation (XLMR).
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Is cellphone use detrimental to mental health? A new study from the University of Illinois finds that addiction to, and not simply use of, mobile technology is linked to anxiety and depression in college-age students.
Neuroscientists at Case Western Reserve University School of Medicine have discovered a new cell type in the part of the brain that processes our sense of smell.
› Verified 8 days ago
Holly Zehfus, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 527 Gott Rd, Enid, OK 73705 Phone: 580-213-7418 | |
Steven Ross Mareburger, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 707 S. Monroe Street, Emergency Department, Enid, OK 73701 Phone: 580-548-1367 Fax: 580-548-1537 | |
Brian W. Cook, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 S Monroe St, Enid, OK 73701 Phone: 580-233-2300 Fax: 580-548-1489 | |
John W Ronck, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 305 S 5th St, Wound Care Dept, Enid, OK 73701 Phone: 580-548-5010 Fax: 580-548-5012 | |
Dr. Michael L. Lawrence, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 310 E Owen K Garriott Rd, Enid, OK 73701 Phone: 580-249-3795 Fax: 580-234-3299 | |
Jeffrey G Hoffsommer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 231 S 30th St, Enid, OK 73701 Phone: 580-233-2900 Fax: 580-233-2902 |